BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
CareEdge Research Report
General Insurers’ December 2022 numbers were up by 13.5%, compared to an increase of 4.2% in December 2021, while for year-to-date-FY23, the growth which has been driven by the group health and motor segments, has been nearly 1.7 times that was witnessed last year.
Standalone private health insurers continued their growth path as December 2022 numbers reached Rs 2,307.7 crore up sequentially from Rs 2,026.3 crore in November 2022, and up from Rs 1,880.1 crore in December 2021.
This monthly growth of 22.7% was significantly slower than the 41.9% reported in December 2021. Meanwhile, the year-to-date-FY23 growth rate too was slower in the current year versus last year.
The slowing was on account of the normalised growth in the government and retail health schemes in the current year, while last year, the same had posted significant growth.
Specialised insurers posted an increase of 15.7% in December 2022 compared to a rise of 27% in December 2021, meanwhile the year-to-date numbers have remained mostly flat as the fall in the participation in crop insurance by a few private sector general insurance companies offset the increase of other companies.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU
![](https://images.assettype.com/bloombergquint/2024-08-26/sne8uwe9/7a6e10b2-14bd-46d9-adfa-0f6ceb144c7c.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Infra Bonds May Not Solve Liquidity Woes For Banks
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08-20/h9u4u1mg/pexels-rethaferguson-3825529.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Serum Institute Developing Mpox Vaccine Amid Rising Global Concerns
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-03/ab6c590b-5663-414a-b887-91012de7900e/fa23e462_521c_42ef_83e0_c7bbcdb055c5.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
GIC Eyes Rs 42,000-43,000 Crore Premium Following Q1 Results
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08/ca5ac28f-4c2b-48f6-9916-456d837948c0/Narayana Hrudayalaya website.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Narayana Health Plans Rs 1,600–1,700-Crore Capex In FY25 To Boost Growth: CFO
![timelogo](/images/amp-time.png)